Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 49.22 | -1.76% | -0.88 |
SWTX closed down 1.76 percent on Thursday, March 28, 2024, on approximately normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Shooting Star Candlestick | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
20 DMA Resistance | Bearish | -1.76% | |
180 Bullish Setup | Bullish Swing Setup | -1.76% | |
Bollinger Band Squeeze | Range Contraction | -1.76% | |
Multiple of Ten Bullish | Other | -1.76% | |
Outside Day | Range Expansion | -1.76% | |
20 DMA Resistance | Bearish | 0.04% |
Alert | Time |
---|---|
Down 1% | about 4 hours ago |
60 Minute Opening Range Breakdown | about 6 hours ago |
Fell Below 10 DMA | about 6 hours ago |
60 Minute Opening Range Breakout | about 9 hours ago |
Up 3% | about 9 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/01/2024
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 53.92 |
52 Week Low | 18.0 |
Average Volume | 1,207,662 |
200-Day Moving Average | 32.65 |
50-Day Moving Average | 47.64 |
20-Day Moving Average | 50.19 |
10-Day Moving Average | 49.79 |
Average True Range | 2.51 |
RSI (14) | 50.00 |
ADX | 19.08 |
+DI | 21.54 |
-DI | 16.83 |
Chandelier Exit (Long, 3 ATRs) | 46.39 |
Chandelier Exit (Short, 3 ATRs) | 54.63 |
Upper Bollinger Bands | 52.51 |
Lower Bollinger Band | 47.88 |
Percent B (%b) | 0.29 |
BandWidth | 9.21 |
MACD Line | 0.55 |
MACD Signal Line | 0.87 |
MACD Histogram | -0.3276 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 53.83 | ||||
Resistance 3 (R3) | 54.31 | 53.25 | 53.06 | ||
Resistance 2 (R2) | 53.25 | 52.08 | 53.01 | 52.80 | |
Resistance 1 (R1) | 51.24 | 51.36 | 50.71 | 50.76 | 52.55 |
Pivot Point | 50.18 | 50.18 | 49.92 | 49.94 | 50.18 |
Support 1 (S1) | 48.17 | 49.01 | 47.64 | 47.69 | 45.89 |
Support 2 (S2) | 47.11 | 48.29 | 46.87 | 45.64 | |
Support 3 (S3) | 45.10 | 47.11 | 45.38 | ||
Support 4 (S4) | 44.62 |